PROJECT NARRATIVE Memantine is a drug used for adult dementia patients that has been shown to decrease the changes in thinking and memory that occur after whole brain radiotherapy in adults with brain metastasis. Based on the mechanism of action and animal models we expect memantine will be effective and safe for reducing short and long-term changes in brain function for children receiving radiation for brain tumors. Reduction of specific brain volumes after radiotherapy are associated with memory and thinking changes and we also hypothesize that neuroprotection with memantine will result in a reduction in volume loss in critical regions of the brain.
|Effective start/end date||9/18/19 → 12/31/22|
- National Cancer Institute: $892,392.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.